Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:GEMP

Gemphire Therapeutics (GEMP) Stock Price, News & Analysis

Gemphire Therapeutics logo

About Gemphire Therapeutics Stock (NASDAQ:GEMP)

Advanced Chart

Key Stats

Today's Range
$0.67
$0.71
50-Day Range
$0.30
$6.38
52-Week Range
$0.24
$1.49
Volume
53,211 shs
Average Volume
127,174 shs
Market Capitalization
$9.98 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive GEMP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Gemphire Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

GEMP Stock News Headlines

“All the land that you see I will give to you and your offspring forever…”
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 trillion vault of untapped American wealth. Former CIA advisor Jim Rickards calls it the “Old Testament Wealth Code” — and says it could transform your financial future. He’s revealing everything in a new presentation.
See More Headlines

GEMP Stock Analysis - Frequently Asked Questions

Gemphire Therapeutics Inc (NASDAQ:GEMP) issued its quarterly earnings data on Friday, March, 15th. The company reported ($0.26) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.41) by $0.15.

Gemphire Therapeutics (GEMP) raised $30 million in an IPO on Friday, August 5th 2016. The company issued 3,000,000 shares at a price of $10.00 per share. Jefferies and RBC Capital Markets served as the underwriters for the IPO and Canaccord Genuity and Roth Capital Partners were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Gemphire Therapeutics investors own include TG Therapeutics (TGTX), AcelRx Pharmaceuticals (ACRX), Pixelworks (PXLW), Clearside Biomedical (CLSD), Protalix BioTherapeutics (PLX), SCYNEXIS (SCYX) and Melinta Therapeutics (MLNT).

Company Calendar

Last Earnings
3/15/2019
Today
7/18/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:GEMP
CIK
1638287
Fax
N/A
Employees
9
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$23.64 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-419.70%
Return on Assets
-173.05%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.67
Quick Ratio
0.67

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.54 per share
Price / Book
1.24

Miscellaneous

Outstanding Shares
14,872,000
Free Float
N/A
Market Cap
$9.98 million
Optionable
Not Optionable
Beta
2.82
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:GEMP) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners